Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease
Clinical trials have demonstrated significant HbA1c reductions with cardiovascular benefits in high-risk patients
8 , e70490 (2025)
These medicines are powerful and effective, but they are not suitable for everyone and need medical supervision
Unlock the full potential of your compounding pharmacy with our comprehensive 3-part webinar series covering critical aspects of GLP-1 compounding, including regulations on popular Semaglutides, enabling your compounding practice to: Remain Compliant Avoid Penalties Maximize Profitability with Innovative Business Models Mitigate Legal Risks Safeguard Intellectual Property Enhance Patient Care Who Should Watch: Access our GLP-1 Compounding webinar anytime, anywhere, fitting seamlessly into the busy schedules of pharmacy owners, pharmacists and pharmacy technicians
Healthcare models are evolving, and those who adapt quickly will be in the best position to support both their members and their bottom line